Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Marta Carrillo-Palau

Has grant

Ph D

Hospital Universitario de Canarias

Spain

Research Interests

Explore related searches

Professors in Spain

Recent Grants

Grant: Close

Farmacocinética de ustekinumab en los pacientes con enfermedad inflamatoria en la práctica clínica habitual en un corte transversal. Estudio NIVUSTEII-1

Open Date: 2020-12-01

Close Date: 2023-11-01

Grant: Close

Evaluación del test inmunológico de sangre oculta en heces en el proceso diagnóstico de pacientes con anemia ferropénica

Open Date: 2017-01-01

Close Date: 2019-12-01

Grant: Close

Comparación del test de sangre oculta en heces y la colonoscopia en el cribado del cáncer colorrectal familiar: análisis de la adherencia, eficacia diagnóstica y coste-efectividad

Open Date: 2016-01-01

Close Date: 2018-12-01

Grant: Close

Papel de las metaloproteinasas plasmáticas como biomarcadores en la prevención del cáncer colorrectal

Open Date: 2014-01-01

Close Date: 2018-06-01

Grant: Close

La cromoendoscopia como técnica de cribado de displasia en pacientes con enfermedad inflamatoria intestinal de larga evolución

Open Date: 2013-06-01

Close Date: 2015-06-01

Articles (19)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Collaborators (15)

Manuel Van Domselaar

Head of Department

Hospital Universitario Quirónsalud Madrid

SPAIN

Marta Carrillo-Palau

Research Interests

Explore related searches

Recent Grants

Articles (19)

HIV Infection Is Associated With a Less Aggressive Phenotype of Inflammatory Bowel Disease: A Multicenter Study of the ENEIDA Registry

Prevalence of Undiagnosed Inflammatory Bowel Disease in Spondyloarthritis Patients

Psoriasis induced by antiTNF therapy in inflammatory bowel disease: Therapeutic management and evolution of both diseases in a nationwide cohort study

Need for therapeutic escalation in patients with refractory ulcerative proctitis: Results from the PROCU study of the ENEIDA registry.

An artificial intelligence-assisted system versus white light endoscopy alone for adenoma detection in individuals with Lynch syndrome (TIMELY): an international, multicentre, randomised controlled trial.

Liver Fibrosis Index-4 Does Not Correlate to Liver Elastography in Patients with Inflammatory Bowel Disease

Association of Serum Malondialdehyde Levels with Lipid Profile and Liver Function in Patients with Inflammatory Bowel Disease

CTNND1 is involved in germline predisposition to early-onset gastric cancer by affecting cell-to-cell interactions

Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registry

Development and validation of a faecal immunochemical test-based model in the work-up of patients with iron deficiency anaemia

Persistence, effectiveness and safety of ustekinumab and vedolizumab therapy for complex perianal fistula in Crohn's disease: The HEAL study from GETECCU

EFFICACY, EFFICIENCY, AND ACCEPTABILITY OF TELEMEDICINE FOR INFLAMMATORY BOWEL DISEASE PATIENTS FOLLOW-UP CARE DURING THE COVID-19 PANDEMIC

Serum Levels of Lipoprotein Lipase Are Increased in Patients with Inflammatory Bowel Disease

Screening uptake of colonoscopy versus fecal immunochemical testing in first-degree relatives of patients with non-syndromic colorectal cancer: A multicenter, open-label, parallel-group, randomized trial (ParCoFit study)

Impact of Biologic Agents on the Immune Response Induced by the Additional Dose of SARS-CoV-2 Vaccine in Inflammatory Bowel Disease Patients

Definition of a therapeutic range for predicting long-term infliximab response in patients with inflammatory bowel disease,Definición de un rango terapéutico para predecir la respuesta al infliximab a largo plazo en pacientes con enfermedad inflamatoria intestinal

Hematological Composite Scores in Patients with Inflammatory Bowel Disease

Collaborators (15)

Manuel Van Domselaar

Manuel Barreiro de Acosta

ALEJANDRO HERNANDEZ CAMBA

Eva Rivas

Inmaculada Alonso Abreu

Cristina Gómez-Moreno

Laura de Armas Rillo

Enrique Quintero

Manuel Hernandez-Guerra

Angel Ponferrada

Iván Ferraz-Amaro

Laura Ramos López

Eva Perez-Pampin

Fernando Gomollón

miriam hernandez-porto

Make your next move.